Rating History for Myriad Genetics (MYGN) by Piper Sandler

More Stocks Rated by Piper Sandler | Latest Ratings for MYGN
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/11/2025 Dave Westenberg Maintain Overweight
(N/A)		 8.50
(9.00)		  
 		   Details